What tests can give similar results as a Positron Emission Tomography (PET) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Several imaging tests can provide similar results to a PET scan, with MRI and CT scans being the most common alternatives, as they offer excellent diagnostic information and are widely available. When considering alternatives to PET scans, it's essential to evaluate the specific condition being investigated.

  • MRI (Magnetic Resonance Imaging) uses powerful magnets and radio waves to create detailed images of organs and tissues, offering excellent soft tissue contrast without radiation exposure, making it a suitable alternative for brain or soft tissue evaluation 1.
  • CT (Computed Tomography) scans use X-rays to create cross-sectional images and are particularly good at detecting bone abnormalities, internal bleeding, and certain tumors, making them a preferred choice for lung nodules 1.
  • SPECT (Single Photon Emission Computed Tomography) is another nuclear medicine test that, like PET scans, uses radioactive tracers but with different technology and typically lower resolution.
  • Functional MRI (fMRI) can assess brain activity similar to PET neuroimaging, providing valuable information on brain function and activity. The choice of alternative imaging test depends on various factors, including availability, cost considerations, the patient's condition, and the specific diagnostic information needed, as highlighted in the study by 1, which discusses the use of FDG-PET/CT in ovarian cancer staging and follow-up. In general, CT scans and MRI are the most commonly used alternatives to PET scans, offering a balance of diagnostic accuracy, availability, and cost-effectiveness. However, the specific choice of imaging test should be tailored to the individual patient's needs and the specific clinical question being addressed, taking into account the latest evidence and guidelines, such as those discussed in 1 and 1.

From the FDA Drug Label

INDICATIONS & USAGE Dipyridamole Injection is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately In a study of about 1100 patients who underwent coronary arteriography and Dipyridamole Injection assisted thallium imaging, the results of both tests were interpreted blindly and the sensitivity and specificity of the dipyridamole thallium study in predicting the angiographic outcome were calculated The sensitivity of the dipyridamole test (true positive dipyridamole divided by the total number of patients with positive angiography) was about 85%. The specificity (true negative divided by the number of patients with negative angiograms) was about 50% In a subset of patients who had exercise thallium imaging as well as dipyridamole thallium imaging, sensitivity and specificity of the two tests were almost identical.

Similar tests to Positron Emission Tomography (PET) scan include:

  • Thallium myocardial perfusion imaging
  • Dipyridamole thallium imaging
  • Exercise thallium imaging
  • Coronary arteriography 2

From the Research

Alternative Imaging Tests to PET Scans

The following tests can provide similar results to Positron Emission Tomography (PET) scans:

  • Single Photon Emission Computed Tomography (SPECT) 3, 4: SPECT is a nuclear medicine tomographic imaging technique that can be used to study regional function and biochemistry.
  • Computed Tomography (CT) scans 5, 6: CT scans can be combined with PET scans to provide both anatomical and functional information.
  • Magnetic Resonance Imaging (MRI) scans 4, 7: MRI scans can be combined with PET scans to provide detailed anatomical information and functional characterization of tumors.
  • Contrast-enhanced PET/MR imaging 7: This technique combines the benefits of PET and MRI to provide detailed information on tumor extent and infiltration of adjacent structures.

Tracers Used in Alternative Imaging Tests

The following tracers can be used in alternative imaging tests:

  • Gallium 67 citrate 3: This tracer can be used in SPECT imaging to detect malignant disease.
  • Monoclonal antibodies labeled with iodine 123 or indium 111 3: These tracers can be used in SPECT imaging to detect specific types of cancer.
  • 18F-FLT 5: This tracer can be used in PET scans to detect cellular proliferation in various malignancies.
  • 68Ga-somatostatin analogues 5, 4: These tracers can be used in PET scans to detect neuroendocrine tumors.
  • Prostate Specific Membrane Antigen (PSMA) 4: This tracer can be used in PET scans to detect prostate cancer.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nuclear Medicine Imaging Procedures in Oncology.

Methods in molecular biology (Clifton, N.J.), 2021

Research

Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2015

Research

Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.